Broegelmann Research Laboratory

Main content

Initiated in 1957 and co-localized and integrated with the Department of Clinical Science (Klinisk Institutt 2), BRL is internationally recognised as one of the leading groups on experimental, clinical and genetic studies of Sjögren's syndrome, see Sjogrens research at BRL (English, Norsk). BRL is closely associated with the Scandinavian Journal of Immunology, Bergen Research School in Inflammation and the Bergen Flow Cytometry Core Facility.

The group is lead by Professor Helena Erlandsson Harris, the Broegelmann chair of translation immunology and head of the Immunology and Rheumatology group.

BRL is composed of several principal investigators (PIs), with current areas of research including translational studies in autoimmunity, functional genomics and genetic basis of autoimmune exocrinopathy, dendritic cells in immunotherapy, host microbe interactions, and hyperinflammatory primary immunodeficiency syndrome.

BRL is multinational research environment with group leaders originating throughout Europe and lab members throughout the world.

Contact us.

General inquiries: Richard Davies, E-mail: Richard.davies@uib.no

Address: Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, The Laboratory Building 5th floor, Haukeland University Hospital

Research into SS at BRL

Sjogrens research at BRL (English)

forskning pa sjogrens syndrom (norsk)

Principal Investigators

Helena Harris group

HEH was appointed professor at UiB, Broegelmann chair of translation immunology and head of the Immunology and Rheumatology group 1st January this (2022). Previously HEH held a position as Professor of Rheumatological inflammation research at Karolinska Institutet, a position which she retains part...

Silke Appel Group

Single cell network profiling of distinct immune cells allows analyzing pathway specific activity of patient samples at the single cell level. This will enable us to stratify different categories of patients and develop personalized therapies. ...

Piotr Mydel Group

The group believes in interdisciplinary cooperation with medical and dental clinicians, epidemiologists, bio-scientists, industrial scientists to achieve their goals of elucidating the role of post-translational modifications in the aetiology of auto immune diseases.

Yenan Bryceson Group

Our research strives to understand the complex regulation of cytotoxic lymphocyte function in health and disease in the setting of human genetic variability and environmental factors.

Marie Wahren-Herlenius Group

The majority of autoimmune diseases are more common in women than in men, but the molecular basis for this sex-bias remains poorly understood. In our projects we focus on the autoimmune exocrinopathy Sjögren's syndrome which has among the highest observed female-to-male ratios, to dissect the...

28.04.2023